Navigation Links
Mirixa Corporation and the APhA Foundation Form Partnership
Date:10/9/2008

APhA Foundation and NCPA Join Forces to Deliver Patient Care via Single

Platform, MirixaPro(SM)

RESTON, Va. and WASHINGTON, Oct. 9 /PRNewswire/ -- Mirixa Corporation and the American Pharmacists Association (APhA) Foundation, the creator of the Diabetes Ten City Challenge and a partner in the Asheville Project(R), jointly announced today that they will form a new partnership that will deliver all of APhA Foundation's HealthMapRx commercial programs via Mirixa. MirixaPro(SM) will be the platform of choice for all existing and future APhA Foundation commercial programs delivered through pharmacy.

This partnership joins the quality and reach of Mirixa-enabled patient care programs and services with the APhA Foundation's highly respected and nationally renowned employer-based disease management and wellness research efforts. Additionally, this enhanced alliance between the National Community Pharmacist Association (NCPA), which sponsors Mirixa, and the APhA Foundation represents a significant opportunity for the pharmacy community by providing enhanced opportunities to deliver patient care services.

"We are delighted to have earned the trust of the APhA Foundation and to be selected as their business partner and pharmacy platform of choice," expressed Rick Solano, Mirixa's Chief Executive Officer. "This partnership represents a significant step forward in enhancing pharmacy-based patient care and education services at the national level, and will help pharmacists improve consumer health and the quality of many lives," added Mr. Solano.

"This important collaboration between national pharmacist organizations has the tremendous potential to incentivize wellness, improve patient outcomes and manage costs, thereby addressing critical issues facing the U.S. healthcare system. The new partnership creates synergies that will provide enhanced service delivery and program offerings to current and future clients and resp
'/>"/>

SOURCE Mirixa Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
2. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
3. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
4. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
5. BioElectronics Corporation Announces Singapore and Malaysia Sales
6. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
7. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
8. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
9. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
10. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
11. Enova Medical Launches Exos Corporation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...stCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today ann... ended September 30, 2009. GenVec reported a net l...e months ended September 30, 2009 compared to a ne...mparable quarter of 2008. For the nine months ende...million ($0.15 per share), compared to a net loss ...
(Date:11/5/2009)...2009 at 4:30 p.m. Eastern Time , BOTHELL, WA ...Genex Pharmaceuticals, Inc. ("OncoGenex" or the "C... financial results for the third quarter and nine ...ompany,s highlights for the third quarter of 2009....the operations of OncoGenex Technologies Inc. ("On...
(Date:11/5/2009)...re-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), a...or-based technologies to discover novel flavor ing...pply industries, today provided a corporate update...ter ended September 30, 2009. Revenues were $4.2 ... $4.0 million for the third quarter of 2008, an in...
(Date:11/5/2009)...ion correction experts listed in the Trusted LASIK...recently concluded American Academy of Ophthalmolo...ifornia. Dr. Stephen Brint, MD, Dr. Frederick Frau...Rapoza, MD, Dr. Michael Raizman, MD, Dr. James McC...che, MD, and Dr. Parag Majmudar, MD, all leading v...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
...derscores Intellect,s Leadership in Immunotherapy ... NEW YORK, Sept. 19 Intellect Neurosciences,Inc. ...mpany focused on,development of disease-modifying ...n of Alzheimer,s disease and related disorders, an...ering chimeric peptide vaccines has,been validated...
...o Develop New Prescription Adult Cough Products Us...Technologies, CHESTER, N.J. and SALT LAKE CITY, S...daq: ARxT ) and Lipocine Inc., a,privately- held,...y,validated proprietary technologies to address ke...y announced that they have entered into a license,...
...s Into License, Commercialization and Supply Agree.... Eastern Time, September 19, ...devus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) today...ugh its acquisition of Esprit Pharma, has obtained...URA(R) XR. In connection with,Allergan,s acquisiti...
Other Biology Technology:Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimer's Vaccine in 19 Countries 2Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimer's Vaccine in 19 Countries 3Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement 2Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement 3Indevus Announces Allergan as New Partner for SANCTURA Brand 2Indevus Announces Allergan as New Partner for SANCTURA Brand 3Indevus Announces Allergan as New Partner for SANCTURA Brand 4Indevus Announces Allergan as New Partner for SANCTURA Brand 5Indevus Announces Allergan as New Partner for SANCTURA Brand 6
(Date:11/8/2009)...EALTH EDUCATION DESIGNED FOR ADULTS WITH INTELLECT...ES , An Indiana University study involving adul...dults increased their personal health knowledge af... Adults with ID, an internationally accepted term...s of obesity, physical inactivity and preventable ...
(Date:11/6/2009)...DELPHIA (November 06, 2009) The Monell Center and...s of the Beijing International Meeting on Taste an...tion with the CAS, the meeting will be the first i... in China. , Alan Leshner, Chief Executive Offic...ience and Executive Publisher of Science magazine,...
(Date:11/4/2009)...ADS: (top news in natural science) , United St... uses less water today than it did 35 years ago, d...in water use are partly attributable to alternativ...nt irrigation systems. According to the latest USG...in the United States goes to cooling thermoelectri...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Monell Center joins with CAS to host Beijing meeting on taste and smell research 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Eight Miami Area Residents Charged in 2422 Million Medicare Fraud Scheme Involving Home Health Care Agencies 50171 1Eight Miami Area Residents Charged in 2422 Million Medicare Fraud Scheme Involving Home Health Care Agencies 50171 2Eight Miami Area Residents Charged in 2422 Million Medicare Fraud Scheme Involving Home Health Care Agencies 50171 3Eight Miami Area Residents Charged in 2422 Million Medicare Fraud Scheme Involving Home Health Care Agencies 50171 4LSUHSC research identifies enzyme that makes survival molecule for key vision cells 50167 1LSUHSC research identifies enzyme that makes survival molecule for key vision cells 50167 2T STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue 9016 1T STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue 9016 2
...fish that belongs to the oldest living family of j...an. , This discovery, published in the March 200...ts, understanding of how color vision evolved in e...f evolution. , "It was unexpected that a ,primit...tential for color vision like humans. The discover...
... Bernard Madoff Ponzi scheme led to the collapse o...ife science research, many bioindustry observers v...uence in the larger economic picture, reports Gen... look at the Madoff factor as representing only on... has been rocked by declining stock prices, additi...
...ation for Dental Research (IADR) has selected Dr. ...chusetts, USA, as the 2009 recipient of the Pharma... award will be presented at the IADR 87th General ...ril 1, 2009,Dr. Papas is the Erling Johansen Profe...partment of General Dentistry at the,Tufts Univers...
Other Biology News:Elephant shark genome sequence leads to discovery of color perception in deep-sea fish 2GEN reports on Madoff scandal's impact on the life sciences 2Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award 2
...ilencing experiments often call for critical, but ...oFX Transfection Agent refines siRNA transfection ...eoFXs lipid-based formulation can be used to effic...tured without increased cytotoxicity. From start ...
Kit for BASE20/50 dual control unit KIT50EHTD from Wave Biotech now part of GE Healthcare
...EMICON® CaspaTag™ Pan-Caspase In Situ As... of active caspases in cells undergoing apoptosis....diagnostic or therapeutic procedures. CHEMICON®...use a novel approach to detect active caspases. Th...
jetSI conc. 10 mM from Polyplus Transfection
Biology Products: